Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 17, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

June 30, 2024

Conditions
AsthmaAirway ObstructionAirway RemodelingParasympathetic Nervous System Diseases
Interventions
DRUG

Salbutamol

Visit 1, After predosed spirometry is done, the patients will be received 4 puffs of salbutamol. 30 minutes later, if they meet the criteria of fixed airway obstruction based on ATS criteria, then they will continue to undergo serial spirometry at 1, 2, 3, and 4 hours. Then, the patients requested to be administered 4 puffs of ipratropium and do spirometry at 4.5 and 5 hours.

DRUG

Ipratropium Bromide

Visit 2, After predosed spirometry is done, the patients will be received 4 puffs of ipratropium they will continue to undergo serial spirometry at 30 minutes,1, 2, 3, and 4 hours. Then, the patients requested to be administered 4 puffs of salbutamol and do spirometry at 4.5 and 5 hours.

DRUG

Salbutamol plus Ipratropium Bromide

Visit 3, After predosed spirometry is done, the patients will be received 4 puffs of a placebo, and they will do spirometry at 30 minutes, 1 and 2 hours (Placebo arm). Then, the patients requested to be administered 4 puffs of ipratropium and 4 puffs of salbutamol and do spirometry at 4.5 and 5 hours (Salbutamol plus ipratropium arm)

OTHER

Placebo

Visit 3, After predosed spirometry is done, the patients will be received 4 puffs of a placebo, and they will do spirometry at 30 minutes, 1 and 2 hours (Placebo arm).

Trial Locations (1)

90110

RECRUITING

Hatyai Hospital, Hat Yai

All Listed Sponsors
lead

Hat Yai Medical Education Center

OTHER